Floatz logo

DEXKETOPROFEN

Spinal Stenosis

Yonsei UniversitySmall moleculeN/AActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
81/ 100

Competitive context

8 Active assets in the Spinal Stenosis cohort.

Asset / SponsorPhaseRating
FENTANYL
Seoul National University Hospital
Phase 4BB
CYCLOHEXANEACETIC ACID, 1-(AMINOMETHYL)-
Seoul National University Hospital
Phase 4B
ec5026
EicOsis Human Health Inc.
Phase 1CC
NORADRENALINE TARTRATE IMPURITY C
Yonsei University
N/AD
Plavix
Yonsei University
N/AD

View all 10 →

Same molecule, other indications

DEXKETOPROFEN is also rated in:

migraine disorderDormant
BBB
Indicative ·
73 / 100
View asset →
migraine without auraDormant
BB
Indicative ·
68 / 100
View asset →
Carcinoma, HepatocellularDormant
BB
Indicative ·
67 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →